BlackBerry Ltd (NASDAQ:BBRY) (TSE:BB) is expected to launch a new tablet by the end of 2015, after failing miserably previously in 2011 in the segment, claims a report from n4bb.com. The company unveiled its debut tablet in 2010 and made it available for purchase in 2011 only to end up without many takers.
Focused on enterprise customers
However, this time the Canadian company is apparently concentrating on the enterprise market and users in high-end industries like medicines. Though the functionality of the tablet would be in line with the requirements of businesses and industrial use, consumers could also avail themselves if interested.
The news has not been confirmed by BlackBerry Ltd (NASDAQ:BBRY) (TSE:BB). Even though the tablet segment is quite a popular one among customers, BlackBerry could not capitalize on it in 2011, with smartphone shares continuing to fall. The probable tablet would focus on the company’s core strength, which is enterprise security and communication features.
BlackBerry Ltd (NASDAQ:BBRY) (TSE:BB)’s Playbook release was subjected to many delays and the device also lacked an app ecosystem, which did not bode well with the customers. Playbook was crippled with many drawbacks, but owners still have a liking for it and would welcome the updated version of the tablet. Before CEO Chen, the company ruled out any tablet release in the future as there was no value in it according to the company. But new management might differ from the previous one.
BlackBerry CEO believes in tablets
A few weeks back at the BlackBerry Experience event, John Sims, President of Enterprise at BlackBerry Ltd (NASDAQ:BBRY) (TSE:BB) replied, when asked about the tablet, “we see value in a tablet and I can tell you that John Chen REALLY likes the idea of a tablet.” The Canadian company thinks that it could sell a tablet successfully to its enterprise customers. Also, the tablet has a chance to become a vital asset in healthcare and other regulated industries. It was reported that BlackBerry and NantHealth are jointly working on a smartphone for the medical sector, which will be available to general consumers as well.
On Wednesday, in pre-market trading BlackBerry Ltd (NASDAQ:BBRY) (TSE:BB) shares were down 0.41% to $7.26.
